Sunshine Biopharma Inc. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Sunshine Biopharma Inc. stock issued during period, value, other for the quarter ending 2021-12-31 was $724.14K, a 5.99% increase year-over-year.
- Sunshine Biopharma Inc. stock issued during period, value, other for the quarter ending 2021-09-30 was $3.74M, a 457.87% increase year-over-year.
- Sunshine Biopharma Inc. stock issued during period, value, other for the quarter ending 2021-06-30 was $3.10M, a 198.31% increase year-over-year.
- Sunshine Biopharma Inc. stock issued during period, value, other for the quarter ending 2021-03-31 was $5.14M, a 4099.77% increase year-over-year.
- Sunshine Biopharma Inc. stock issued during period, value, other for fiscal 2021 was $12.71M, a 405.17% increase from fiscal 2020.
- Sunshine Biopharma Inc. stock issued during period, value, other for fiscal 2020 was $2.52M.
- Sunshine Biopharma Inc. stock issued during period, value, other for fiscal 2018 was $174.81K, a 208.30% increase from fiscal 2017.
- Sunshine Biopharma Inc. stock issued during period, value, other for fiscal 2017 was $56.70K.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2021-12-31 | $724.14K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-04 | $12.71M 10-K · filed 2023-04-04 |
| 2021-09-30 | $3.74M 10-Q · filed 2022-11-07 | $12.66M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $3.10M 10-Q · filed 2022-08-03 | $9.59M derived: sum of 4 quarters · filed 2022-08-03 |
| 2021-03-31 | $5.14M 10-Q · filed 2022-05-06 | $7.53M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $683.20K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $2.52M 10-K · filed 2022-03-21 |
| 2020-09-30 | $671.13K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $1.04M 10-Q · filed 2021-08-09 | |
| 2020-03-31 | $122.38K 10-Q · filed 2021-05-11 | |
| 2019-09-30 | $292.31K 10-Q · filed 2020-11-12 | $647.76K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $103.86K 10-Q/A · filed 2020-08-31 | $333.86K derived: sum of 4 quarters · filed 2020-08-31 |
| 2019-03-31 | $47.31K 10-Q · filed 2020-05-18 | |
| 2018-12-31 | $204.28K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-12 | $174.81K 10-K · filed 2019-04-12 |
| 2018-09-30 | -$21.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | |
| 2017-12-31 | $56.70K 10-K · filed 2019-04-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |